Life sciences organizations are navigating rapid shifts in specialty medicine, rare disease engagement, and global compliance expectations. This webinar explores how evolving specialty economics, rare disease tiering challenges, and the push for global harmonization are reshaping HCP fair market value strategies. Attendees will gain insights into building FMV frameworks that remain defensible, competitive, and adaptable across diverse markets.

Discussion Highlights:

• How specialty market dynamics are influencing FMV benchmarks and compensation expectations
• Methods for tiering rare disease experts while maintaining compliance and defensibility
• Strategies to harmonize FMV approaches globally without losing local accuracy
• Key considerations for sustaining compliance in a highly scrutinized environment

Join us to deepen your understanding of FMV trends and equip your organization with the tools to stay competitive and compliant in a complex global landscape.